EUVIMEDEUVIMED entdecken
Crossref

Genetic Polymorphism of Interleukin-6 in Asymptomatic and ICU-Admitted COVID-19 Patients in Sulaymaniyah Province, Kurdistan Region of Iraq

Peshnyar M A Rashid iD, Gaza F Salih

Genetic Testing and Molecular Biomarkers · 2024

DOI: 10.1089/gtmb.2023.0304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetic Testing and Molecular Biomarkers, 2024. Verfasst von Peshnyar M A Rashid und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Laboratory Science Department, Komar University of Science and Technology, Sulaymaniyah, Iraq. Hauptthemen laut MEDLINE: COVID-19, Interleukin-6, Polymorphism, Single Nucleotide, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The global pandemic of Coronavirus Disease 2019 (COVID-19) has resulted in significant fatality rates. Clinical outcomes for affected individuals range from being asymptomatic to severe illnesses requiring intensive care unit (ICU) admission. Among the various factors contributing to the variation in clinical outcomes, host genetics play a prominent role. Interleukin-6 (IL6), a key player in immune responses, has been identified as having a crucial impact on viral infections, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Specifically, certain variations known as single nucleotide polymorphisms (SNPs) in the IL6 promoter region have been found to significantly influence IL6 expression and the severity of viral infections. Materials and Methods: To explore the relationship between these genetic variations and COVID-19 in asymptomatic and ICU-admitted Kurdish patients, genetic sequencing was performed to determine the genotypes of nine IL6 SNPs.

Results

The study findings revealed that although the proportion of the GG genotype of rs1800795 was slightly higher in asymptomatic COVID-19 cases, the difference was not statistically significant (chi2 = 2.666, p = 0.236). Notably, Kurdish patients displayed a uniform genetic makeup (monomorphic) for the dominant alleles of rs2069830 (C), rs142759801 (C), rs2069857 (C), rs2069829 (G), rs2234683 (G), rs13447446 (T), rs527770772 (C), and rs13447445 (C). Furthermore, patients carrying the haplotype GCGGCTCCC were found to have a 0.481-fold higher likelihood of being asymptomatic with COVID-19 (p = 0.016, OR = 0.481).

Conclusions

This study demonstrates that the rs1800795 SNP is not statistically associated with COVID-19 at the genotype level. However, the presence of the dominant G allele of rs1800795 in the haplotype was found to be statistically associated with asymptomatic COVID-19 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Interleukin-6Polymorphism, Single NucleotideSARS-CoV-2Intensive Care UnitsHumansMaleFemaleIraqAdultMiddle AgedGenotypeHaplotypesGenetic Predisposition to DiseaseAllelesPromoter Regions, GeneticGene Frequency

Stichwörter der Autor:innen

COVID-19ICUIL6SARS-CoV-2cytokine

Substanzen

Interleukin-6IL6 protein, human

Autor:innen und Institutionen

  • Medical Laboratory Science Department, Komar University of Science and Technology, Sulaymaniyah, Iraq.
  • Department of Biology, College of Science, University of Sulaimani, Sulaimaniyah, Iraq.

ORCID-Profile: Peshnyar M A Rashid

Zitieren

APA

Rashid, P. M. A., & Salih, G. F. (2024). Genetic Polymorphism of Interleukin-6 in Asymptomatic and ICU-Admitted COVID-19 Patients in Sulaymaniyah Province, Kurdistan Region of Iraq. Genetic Testing and Molecular Biomarkers. https://doi.org/10.1089/gtmb.2023.0304

Vancouver

Rashid PMA, Salih GF. Genetic Polymorphism of Interleukin-6 in Asymptomatic and ICU-Admitted COVID-19 Patients in Sulaymaniyah Province, Kurdistan Region of Iraq. Genetic Testing and Molecular Biomarkers. 2024. doi:10.1089/gtmb.2023.0304

BibTeX
@article{Rashid2024,
  author = {Rashid, Peshnyar M A and Salih, Gaza F},
  title = {Genetic Polymorphism of Interleukin-6 in Asymptomatic and ICU-Admitted COVID-19 Patients in Sulaymaniyah Province, Kurdistan Region of Iraq},
  journal = {Genetic Testing and Molecular Biomarkers},
  year = {2024},
  doi = {10.1089/gtmb.2023.0304}
}
Kostenlos starten →